Oct 24, 2016
On Tuesday, October 25th, IvyFon will host a seminar on Family Office Trends. This event is oriented towards persons in the Family Office industry working primarily for single family offices, Ultra High Net Worth Individuals as well as multi-family offices. They will...
Oct 20, 2016
In the Life Sciences universe, most people think of biopharma and medical devices as two separate businesses — never shall the two paths cross. However, there are many overlaps and best practices that can be applied to both sectors. It is widely accepted that...
Oct 14, 2016
In any transaction process, two of the most important considerations for a company are: 1) where to draw the line as to what is considered confidential information 2) at what point confidential information is shared. The dividing line of what is and isn’t confidential...
Oct 6, 2016
While life sciences companies are, first and foremost, scientific organizations working to advance human healthcare, they are also businesses. And, all businesses, I would argue, have to participate in the sales process on many levels. At Locust Walk, we are immersed...
Sep 28, 2016
Last week’s accelerated approval of Sarepta’s drug, Exondys 51™ (eteplirsen), for the treatment of a subset of Duchenne Muscular Dystrophy (“DMD”) patients, was an example of the amazing promise, and associated volatility within the biotech industry. We, at Locust...
